Home / Plerixafor / United States
US ATC L03AX16 · updated 2 Nov 2026
Plerixafor shortage in United States
Is there a Plerixafor shortage in United States?
Yes. As of 2 Nov 2026, 1 Plerixafor product is reported short in United States, the first since 13 Mar 2026. No return date has been given. Main reason: not stated.
Also short in Germany, France, Ireland, Austria, Belgium, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12) discontinuation | Fresenius Kabi USA, LLC | 13 Mar 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).